SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905718-21-000130
Filing Date
2021-02-04
Accepted
2021-02-04 16:06:13
Documents
2
Period of Report
2021-02-04

Document Format Files

Seq Description Document Type Size
1 timber_fm3feb42021.html 3  
1 timber_fm3feb42021.xml 3 1635
2 EX-24 mendelsohn_poa.htm EX-24 5131
  Complete submission text file 0000905718-21-000130.txt   8412
Mailing Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677 973-314-9570
Timber Pharmaceuticals, Inc. (Issuer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TIMBER PHARMACEUTICALS, INC. 50 TICE BLVD., SUITE A26 WOODCLIFF LAKE NJ 07677
Business Address
Mendelsohn Alan (Reporting) CIK: 0001842511 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37411 | Film No.: 21591156